This digital product contains the 89 Pace Setters Picks science sessions presented at Heart Rhythm 2023.
The Late-Breaking Clinical Trials category includes the following sessions from Heart Rhythm 2023:
Shark Tank: Hooking AFib
Radiation Reduction Techniques in Ablation of Cardiac Arrhythmias
Cardiac Radiation Therapy for Management of Refractory Ventricular Tachycardia: Methods, Mechanisms, and Outcomes
What is the Best Ablation Strategy for Paroxysmal AF Patients With AF Recurrence and Isolated Pulmonary Veins
Catheter Ablation of Persistent Atrial Fibrillation Beyond PVI: An Update
CardioNeuroAblation for Treating Bradyarrhythmias and Atrial Fibrillation
Complex Atrial Flutter and Atrial Tachycardia Ablation - Advanced Techniques for Challenging Cases
The Evolution of PVI Technologies
How to Summit the Left Ventricular Summit: Methods for Optimizing Ablation Success
First-line Ablation for Atrial Fibrillation: Are We There Yet?
Catheter Ablation Should Be First-line Treatment for Ventricular Tachycardia
Calming the Storm: Methods to Ablate Ventricular Fibrillation
Ventricular Tachycardia Mechanisms and Insights, Focus on Substrate and Imaging
Going Deep: Innovative Techniques for Targeting Intramural Arrhythmogenic Substrate for Ventricular Arrhythmias
Learning Through Burning, the Hard Way: How the Experts Manage Complications
Ablation for Treatment of Neurocardiogenic Syncope
Alcohol for Ablation: How to
When, Why and How to Safely Perform Epicardial Access?
Nightmares in EP Happen Everywhere
Pearls and Pitfalls of Epicardial Mapping and Ablation
Device Clinic Staff Hiring, Training, and Retention
Obstructive Sleep Apnea -Improving Screening, Treatment and Compliance with PAP Therapy in Patients with Atrial Fibrillation
Patient Care After the Implant - Building the Business of a Device Clinic
Just a Generator Change?
Becoming a Master CIED Troubleshooter
End of Life Programming in Palliative Situations, Proactive and Reactive
Remote Monitoring: Navigating Through an Overwhelming Process
New Discoveries in Cardiac Conduction System
Cardiac Optogenetics: Lighting the Way to Better Anti-arrhythmic Therapies
Sex Differences in Cardiac Electrophysiology and Arrhythmogenesis
Contributions of Structural Remodeling to Maintenance of Atrial Fibrillation
Neural Control of the Heart Mechanisms and Therapeutics
Going for the Jugular: Alternative Routes for Device Implantation
Lead Management: Periprocedural Imaging, Debulking of Vegetations and What to Do When Lead Extraction Fails
ECG in Conduction System Pacing: An Essential Tool for Success?
How to Choose the Type Conduction System Pacing
Out of the Box: Innovations in Pacing for Heart Failure
Novel CIED Devices
Reducing CIED-Related Infection
Difficult Implants in the Conduction System: Tips and Tricks from the Experts
Update on Transvenous Lead Extraction: Outcomes, Tools, Tips and Tricks
CSP Should Be First-line for Guideline-indicated Cardiac Resynchronization Therapy
Troubleshooting Complex ECGs of Conduction System
Conduction System Pacing
ICDs in Special Populations: Addressing Gaps in the Guidelines
Controversies in ICD, CRT and CSP Therapy Indications
Debate: Pill in Pocket Anticoagulation for Stroke Prevention in AF
Cardiac Sarcoidosis: A Multidisciplinary Approach to Diagnosing and Treating a Challenging Disease
The Cardio-OB Patient
Sudden Cardiac Death: Spotlight on Novel Developments
Acute Management of Atrial Fibrillation: Current Challenges and Unmet Needs
Challenging SVT Cases
Debate: Post-Watchman Leaks Less Than 5 mm Should be Closed
All About Inappropriate Sinus Tachycardia
Arrhythmias and Athletes
How I Manage PVCs, a Practical Guide
Screening for Atrial Fibrillation
A Multidisciplinary Approach to Afib Care
Board Review for EP Fellows - SVT Session
Board Review for EP Fellows - Ventricular Arrhythmia Session
The HRS/APHRS/LAHRS Guideline on Cardiac Physiologic Pacing for the Avoidance and Mitigation of Heart Failure
All About Mitral Valve Prolapse, Disjunction and Arrhythmias
Provocative New Trials in EP
Sudden Cardiac Arrest on the Athletic Field
Heart Rhythm Presents: New Advances in Conduction System Pacing and the Risk Stratification of Cardiac Arrhythmias
Best of Heart Rhythm O2
Best of Heart Rhythm Case Reports for 2022
Cutting-edge Science in Channelopathies and Cardiomyopathies
Using Artificial Intelligence to Diagnose Arrhythmias
Digital Health and the EP Patient: Beyond the Pandemic
Digital Health Technologies: Promises and Challenges to EP
Managing Digital Health in EP Practices
Innovation in EP: Getting from Here to There
Wearable Technology in Pediatric and Congenital EP
Roundtable/FDA: The ABCs of EFS: Discussion of Early Feasibility Studies in EP with the FDA, Investigators, and Industry. Presented by the Medical Device Innovations Consortium
Why Does CMS Have it Out for Me? How to Make Sense of Reimbursement and Ensure We Change the Future of Downward Cuts
Antiarrhythmic Effects of Heart Failure Medications: Treating Two Birds With One Stone
Cardiac Sarcoidosis: Lessons Learned Around the Globe
My Approach to Ablation in Challenging Locations
EP Issues After Pulmonary and Tricuspid Valve Replacements
Pacing Strategies in Pediatric and Congenital Heart Disease
My 40-year-old Fontan Patient Should be Ablated by an Adult Electrophysiologist
No Abandoned Leads! Pacing and ICD Leads Should Always be Extracted in Pediatric and ACHD Patients
Expert Opinion: Approaches to Challenging Cases in Pediatrics
Controversies in Fetal Arrhythmia Management
Direct to Consumer Heart Rhythm Monitoring: What is Available and What Data Do We Have?
A Primer on Polygenic Scores: Just Another Genetic Test?
If You Build It, Will They Come? Strategies for Practice Management and Growth
I Just Got a Pay Cut! RVU, VBC - OMG: Can & Should We Make Everybody Whole?
Equity in Heart Rhythm Research - Studying Representative Populations and Training Representative Investigators
Learning objectives specific to the session are listed at the individual session within Heart Rhythm 2023 On Demand - Pace Setters Picks.
This activity is designed for all professionals who participate in the care and management of heart rhythm disorders.
Accreditation Statement
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians AMA Designation Statement
The Heart Rhythm Society designates this internet enduring activity for a maximum of 65.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM Maintenance of Certification (MOC) Statement
Successful completion of this ACE activity, which includes participation in the evaluation component, enables the participant to earn up to 65.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of ACE credits claimed for the activity. It is the ACE activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College of Physicians and Surgeons of Canada MOC Recognition Statement
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “ACE in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Other Credit Available
A Credit Certificate (for physicians) or Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:
· American Academy of Family Physicians (AAFP) (for elective credit)
· American Academy of Nurse Practitioners Certification Board (AANPCB)
· American Academy of Physician Assistants (AAPA)
· American Nurses Credentialing Center (ANCC)
· American Osteopathic Association (AOA) (for Category 2 credit)
· Committee on Accreditation of Continuing Medical Education (Canada)
· European Board for Accreditation in Cardiology (EBAC)
· European CME Credits (ECMEC)
· German Chambers of Physicians
· National Society of Genetic Counselors (for Category 2 credit)
· Oman Medical Specialty Board
· Qatar Council for Healthcare Practitioners
· Royal College of Physicians and Surgeons of Canada (RCPSC)
Disclosure Policy
The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.
Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.
ACCME Definition:
*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Examples of such organizations include:
Advertising, marketing, or communication firms whose clients are ineligible companies
Bio-medical startups that have begun a governmental regulatory approval process
Compounding pharmacies that manufacture proprietary compounds
Device manufacturers or distributors
Diagnostic labs that sell proprietary products
Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
Manufacturers of health-related wearable products
Pharmaceutical companies or distributors
Pharmacy benefit managers
Reagent manufacturers or sellers
All relevant financial relationships have been mitigated. Individual disclosures will be shown at the session level.
For a comprehensive list of all disclosures, please visit:
Heart Rhythm 2023 Disclosures - Google Sheets
ACE Certificates will be awarded and available to download and print following the completion of the course and the course evaluation. Should you have any questions regarding your ACE certificate, please contact CME@HRSonline.org.